Evidence map›Paper›PMID 41714562›Full record

ArticleStem cell reviews and reports2026

Creating Engineered NAC Flaps Using in Vivo Revascularization: A Proof-Of-Concept Study.

Yanis Berkane, Alperen Abaci, Bradley W Ellis, Loïc van Dieren, Edvin Hendi, Haizam Oubari, Nicolas Bertheuil, Ruben Oganesyan, Curtis L Cetrulo, Michelle E McCarthy and 3 more

Abstract read
In one paragraph

Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yanis BerkaneCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. yanis.berkane@chu-rennes.fr.
Alperen AbaciCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Bradley W EllisCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Loïc van DierenCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Edvin HendiCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Haizam OubariCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Nicolas BertheuilDepartment of Plastic, Reconstructive and Aesthetic Surgery, CHU de Rennes, University of Rennes, Rennes, 35000, France.
Ruben OganesyanCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Curtis L CetruloShriners Children's Boston, Boston, MA, 02114, USA.
Michelle E McCarthyCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Mark A RandolphShriners Children's Boston, Boston, MA, 02114, USA.
Alexandre G LellouchShriners Children's Boston, Boston, MA, 02114, USA.
Basak E UygunCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. basakuygun@mgh.harvard.edu.

Funding

Development of engineered fasciocutaneous skin flapsR01AR082825 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Basak Elif Uygun · 2023 to 2026
$1.4M
Development of Capillary-on-Chip for the Study of Preservation Injury on Microvascular Endothelial CellsF32HL176334 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Bradley Wayne Ellis · 2024 to 2026
$242k
NHLBI NIH HHS F32 HL176334NIAMS NIH HHS R01 AR082825
6 · The paper itself

Abstract

Acellular scaffold revascularization is the most significant challenge in tissue and organ engineering. To achieve successful and durable cell growth within complex three-dimensional scaffolds, a functional vascular network must ensure the supply of oxygen and nutrients within the matrix structure. Several teams have studied in vitro and ex vivo re-endothelialization using dynamic cell seeding and bioreactors, among other techniques. Still, to date, no approach has demonstrated long-term successful and functional vascular tree growth within 3D scaffolds. Herein, we propose a promising alternative using the in vivo implantation of decellularized nipple-areolar complex (NAC) scaffolds on a prepared vascular pedicle, thereby achieving engineered flap creation. We compared two implanted groups, one with and one without vascular micropunctures. After 3 weeks, explanted scaffolds demonstrated successful in-depth capillary growth, supported by contrast angiography, histology (including CD31 staining), and macroscopic bleeding. Flow cytometry assays identified different cell contingents, including CD45 and CD31-positive. No significant difference was found between the two implanted groups. This proof-of-concept study offers valuable insights into the successful engineering of composite tissues and organs.

Indexed as

Neovascularization, PhysiologicSurgical FlapsTissue EngineeringTissue ScaffoldsAnimalsFemaleHumansPlatelet Endothelial Cell Adhesion Molecule-1Proof of Concept StudyPlatelet Endothelial Cell Adhesion Molecule-1

Identifiers

PMID41714562
PMCPMC13099687

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.